Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Erbium YAG Laser vs Tranexamic Acid for Melasma
NCT06522984Recruiting
- Sponsor
- Egymedicalpedia
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in melasma (3 arms), sponsored by Egymedicalpedia. Primary endpoint: Refractory Melasma Treatment combination with topical hydroquinone at 3 months. Started Jun 2024; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
melasma
Beyond the preview
Go deeper on NCT06522984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06522984.